{"entity":{"id":"nct06334432","kind":"trial","name":"Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors","aka":[],"tldr":"A phase 1/2 trial of NUV-1511 in prostate cancer, pancreatic ductal adenocarcinoma and ovarian cancer, run by Nuvation Bio Inc., active and no longer recruiting.","summary":"Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06334432 by Nuvation Bio Inc., with 466 participants enrolled, started 2024-03-14 and due to reach its primary completion in 2027-03. Interventions recorded: NUV-1511.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06334432","url":"https://clinicaltrials.gov/study/NCT06334432"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["prostate","pancreatic","ovarian"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["nuvation-bio"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06334432","phase":"1/2","setting":"A Phase 1/2, First-in-Human, Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors","sponsor":"Nuvation Bio Inc.","enrolled":466,"outcomes":[]},"route":"/trials/nct06334432/","neighbours":{"cancer":[{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"},{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"company":[{"id":"nuvation-bio","kind":"company","name":"Nuvation Bio","route":"/companies/nuvation-bio/"}],"drug":[{"id":"nuv-1511","kind":"drug","name":"NUV-1511","route":"/drugs/nuv-1511/"}]}}